STAAR Surgical
STAA | NASDAQ
$20.75
+$0.43 (+2.12%)
Sep 22, 2026, 1:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Jan 1, 2026 | FY 2024 Dec 26, 2024 | FY 2023 Dec 28, 2023 | FY 2022 Dec 29, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -14.57 | -59.05 | 70.93 | 58.48 | 175.58 | 609.38 |
PEG Ratio | -0.05 | 0.31 | -1.51 | 0.98 | 0.59 | -10.26 |
PS Ratio | 4.89 | 3.79 | 4.70 | 8.19 | 18.70 | 22.10 |
PB Ratio | 3.40 | 2.99 | 3.92 | 6.93 | 16.67 | 18.32 |
P/FCF Ratio | -29.21 | -155.08 | -421.37 | 132.29 | 142.17 | 287.94 |
P/OCF Ratio | -34.17 | 75.63 | 103.77 | 65.22 | 98.05 | 172.44 |
OCF/S Ratio | -14.30 | 5.01 | 4.53 | 12.56 | 19.07 | 12.82 |
Debt / Equity Ratio | 0.11 | 0.10 | 0.09 | 0.09 | 0.12 | 0.05 |
Quick Ratio | 3.74 | 4.62 | 5.08 | 5.56 | 5.21 | 4.81 |
Current Ratio | 4.55 | 5.23 | 5.62 | 6.03 | 5.56 | 5.25 |
Asset Turnover | 0.52 | 0.62 | 0.66 | 0.68 | 0.67 | 0.64 |
Interest Coverage | n/a | n/a | n/a | n/a | 877.34 | n/a |
Return on Equity | -23.37% | -5.09% | 5.53% | 11.80% | 10.64% | 3% |
Return on Assets | -17.43% | -3.97% | 4.37% | 9.47% | 7.96% | 2.30% |
Return on Invested Capital | -11.26% | -2.85% | 4.16% | 10.29% | 9.75% | 2.20% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 76.19% | 76.32% | 78.36% | 78.55% | 77.51% | 72.41% |
Net Profit Margin | -33.60% | -6.44% | 6.62% | 13.95% | 11.94% | 3.62% |
Pretax Profit Margin | -34.36% | -2.88% | 10.45% | 16.02% | 13.58% | 5.06% |
Operating Profit Margin | -19.19% | -4.02% | 8.71% | 15.40% | 14.47% | 4.14% |
FCF Margin | -16.73% | -2.44% | -1.11% | 6.19% | 13.15% | 7.68% |
EBITDA Margin | -30.71% | -0.69% | 12.04% | 17.60% | 15.18% | 6.03% |
Add to Watchlist
Select watchlists to add or remove STAA